Abstract
To the Editor: Dupilumab has been associated with ocular side effects in 30% to 50% of patients, mostly including mild dryness and redness that respond to over-the-counter topical lubricants.1-4 However, most studies have not systematically included formal ophthalmologic examinations that may identify more comprehensive ocular pathologies.5 Herein, we report a 5-year retrospective review of patients treated with dupilumab evaluated at an academic ophthalmology center.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
